Medications

Anti-clot drug recommended for new approval in EU

(AP)—Advisers to European Union regulators have recommended approval of a new anti-clotting drug for use by adults with a common irregular heart rhythm that boosts risk of strokes or blood clots, drugmakers Bristol-Myers ...

Oncology & Cancer

Certain heart meds may give chemo a boost

(HealthDay) -- When common heart drugs such as digitalis and digoxin are combined with some chemotherapy drugs, the effect appears to be an increase in the death of cancer cells, according to French researchers.

Medications

FDA issues multiple sclerosis drug alert

(HealthDay) -- The multiple sclerosis drug Gilenya (fingolimod) should not be given to patients with certain pre-existing or recent heart conditions or stroke, or those taking certain medications to correct heart rhythm problems, ...

Diseases, Conditions, Syndromes

Thyroid condition linked to heart problems: study

(HealthDay) -- New evidence suggests that a type of overactive thyroid condition appears to boost the risk of heart problems, especially atrial fibrillation (a form of irregular heartbeat) and premature death.

Cardiology

Stroke risk high when anti-clotting drugs stopped

Some patients with irregular heartbeats who are taken off anti-clotting medication face a high risk of stroke or blood clotting within a month, according to new research presented at the American Heart Association's Emerging ...

Medical research

Molecule movements that make us think

Every thought, every movement, every heartbeat is controlled by lightning-quick electrical impulses in the brain, the muscles, and the heart. But too much electrical excitability in the membranes of the cells can cause things ...

page 24 from 30